Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
3(33%)
Results Posted
75%(3 trials)
Terminated
2(22%)

Phase Distribution

Ph phase_1
3
33%
Ph phase_2
3
33%
Ph early_phase_1
1
11%

Phase Distribution

4

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 1Safety & dosage
3(42.9%)
Phase 2Efficacy & side effects
3(42.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

3

trials recruiting

Total Trials

9

all time

Status Distribution
Active(3)
Completed(4)
Terminated(2)

Detailed Status

Completed4
Recruiting3
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
9
Active
3
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (14.3%)
Phase 13 (42.9%)
Phase 23 (42.9%)

Trials by Status

terminated222%
recruiting333%
completed444%

Recent Activity

3 active trials
Showing 5 of 9
terminatedphase_1

Novel PET Radioligand as an Inflammatory Biomarker in Musculoskeletal Conditions

NCT03912428
recruitingphase_2

Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease

NCT04576793
completed

CNS Correlates of Extended Sleep Restriction

NCT05547880
recruitingphase_2

Discovery and Validation of Genetic Variants Affecting Microglial Activation in Alzheimer's Disease

NCT04840979
completedphase_1

Imaging Inflammation in Alzheimer's Disease With 11C-ER176

NCT03744312
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT03912428Phase 1

Novel PET Radioligand as an Inflammatory Biomarker in Musculoskeletal Conditions

Terminated
NCT04576793Phase 2

Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease

Recruiting
NCT05547880

CNS Correlates of Extended Sleep Restriction

Completed
NCT04840979Phase 2

Discovery and Validation of Genetic Variants Affecting Microglial Activation in Alzheimer's Disease

Recruiting
NCT03744312Phase 1

Imaging Inflammation in Alzheimer's Disease With 11C-ER176

Completed
NCT04510168

Accelerated Non-Atherosclerotic Brain Arterial Aging Relationship to Alzheimer's Disease

Completed
NCT03958630Phase 1

PET Imaging of Neuroinflammation in Neurodegenerative Diseases Via a Novel Translocator Protein (TSPO) Radioligand

Terminated
NCT06384378Phase 2

Systemic and Central Inflammation in AD

Recruiting
NCT02147392Early Phase 1

Assessment of [11C]ER176 to Image Translocator Protein in Brain and Whole Body of Healthy People

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9